AU763088B2 - Morpholino ethers - Google Patents

Morpholino ethers Download PDF

Info

Publication number
AU763088B2
AU763088B2 AU42588/99A AU4258899A AU763088B2 AU 763088 B2 AU763088 B2 AU 763088B2 AU 42588/99 A AU42588/99 A AU 42588/99A AU 4258899 A AU4258899 A AU 4258899A AU 763088 B2 AU763088 B2 AU 763088B2
Authority
AU
Australia
Prior art keywords
methyl
optionally substituted
compound
carboxylic acid
formyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42588/99A
Other languages
English (en)
Other versions
AU4258899A (en
Inventor
Jose M. Bueno
Jesus Chicharro Gonzalo
Jose-Miguel Coteron
Juan Carlos Cuevas
Jose M. Fiandor
Araceli Mallo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Enzymes LLC
Original Assignee
Glaxo Wellcome SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome SA filed Critical Glaxo Wellcome SA
Publication of AU4258899A publication Critical patent/AU4258899A/en
Application granted granted Critical
Publication of AU763088B2 publication Critical patent/AU763088B2/en
Assigned to VERENIUM CORPORATION reassignment VERENIUM CORPORATION Request to Amend Deed and Register Assignors: GLAXO WELLCOME S.A.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU42588/99A 1998-05-11 1999-05-07 Morpholino ethers Ceased AU763088B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP98500117 1998-05-11
EP98500117 1998-05-11
EP98500204 1998-09-18
EP98500204 1998-09-18
PCT/EP1999/003139 WO1999058512A1 (fr) 1998-05-11 1999-05-07 Ethers de morpholine

Publications (2)

Publication Number Publication Date
AU4258899A AU4258899A (en) 1999-11-29
AU763088B2 true AU763088B2 (en) 2003-07-10

Family

ID=26151831

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42588/99A Ceased AU763088B2 (en) 1998-05-11 1999-05-07 Morpholino ethers

Country Status (13)

Country Link
EP (1) EP1077959A1 (fr)
JP (1) JP2002514632A (fr)
KR (1) KR100625146B1 (fr)
CN (1) CN1174971C (fr)
AR (1) AR016261A1 (fr)
AU (1) AU763088B2 (fr)
BR (1) BR9910377A (fr)
CA (1) CA2331584A1 (fr)
MA (1) MA26628A1 (fr)
PE (1) PE20000479A1 (fr)
TR (1) TR200003301T2 (fr)
TW (1) TW585858B (fr)
WO (1) WO1999058512A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002023541A1 (fr) * 2000-09-13 2002-03-21 Sankyo Company, Limited Dérivés de zofimarin présentant un noyau oxazépame
RU2259825C9 (ru) * 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
JP6640750B2 (ja) * 2015-01-30 2020-02-05 日油株式会社 カチオン性脂質

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711784A1 (fr) * 1994-11-08 1996-05-15 Glaxo, S.A. Dérivés de Sordarin antifongiques
EP0711783A1 (fr) * 1994-11-08 1996-05-15 Glaxo, S.A. Dérivés de Sordarin antifongiques
EP0712859A1 (fr) * 1994-11-08 1996-05-22 Glaxo, S.A. Dérivés de Sordarin antifongiques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465771A (de) * 1965-12-06 1968-11-30 Sandoz Ag Verfahren zur Herstellung eines neuen Antibioticums
JPH0615555B2 (ja) * 1985-08-14 1994-03-02 三共株式会社 抗生物質ゾフイマリン
WO1996014326A1 (fr) * 1994-11-08 1996-05-17 Glaxo Wellcome S.A. Derives de sordaridine a action antifongique
US6177457B1 (en) * 1996-05-08 2001-01-23 Glaxo Wellcome S.A. Process for the preparation of indacene compound
AU729659B2 (en) * 1996-09-18 2001-02-08 Merck & Co., Inc. Sordarin and derivatives thereof for use as crop antifungal agents
AU717019B2 (en) * 1996-10-07 2000-03-16 Merck & Co., Inc. Sordarin derivatives
EP1007031B1 (fr) * 1997-08-22 2003-06-04 Merck & Co., Inc. Derives de 4-cyano-4-deformylsordarine
PL338678A1 (en) * 1997-08-22 2000-11-20 Merck & Co Inc Derivatives of 4-cyano-4-deformylsordacin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711784A1 (fr) * 1994-11-08 1996-05-15 Glaxo, S.A. Dérivés de Sordarin antifongiques
EP0711783A1 (fr) * 1994-11-08 1996-05-15 Glaxo, S.A. Dérivés de Sordarin antifongiques
EP0712859A1 (fr) * 1994-11-08 1996-05-22 Glaxo, S.A. Dérivés de Sordarin antifongiques

Also Published As

Publication number Publication date
MA26628A1 (fr) 2004-12-20
PE20000479A1 (es) 2000-05-29
EP1077959A1 (fr) 2001-02-28
CA2331584A1 (fr) 1999-11-18
AR016261A1 (es) 2001-06-20
JP2002514632A (ja) 2002-05-21
TW585858B (en) 2004-05-01
AU4258899A (en) 1999-11-29
TR200003301T2 (tr) 2001-02-21
BR9910377A (pt) 2001-01-16
CN1174971C (zh) 2004-11-10
KR20010025009A (ko) 2001-03-26
WO1999058512A1 (fr) 1999-11-18
CN1309651A (zh) 2001-08-22
KR100625146B1 (ko) 2006-09-20

Similar Documents

Publication Publication Date Title
EP1911749B1 (fr) Nouveaux agoniste béta-2 à action prolongée et leur utilisation en tant que médicament
EP1761509B1 (fr) Dérivés de cycloalkyle pour le traitement des maladies respiratoires
EP1720546B1 (fr) Nouveaux beta-2-agonistes a action longue duree et leur utilisation comme medicaments
PL190032B1 (pl) Nowe pochodne benzoazepiny, środki lecznicze zawierające te pochodne i ich stosowanie do wytwarzania środków leczniczych
WO2005110990A1 (fr) Heterocycles benzocondenses substitues par hydroxy utilises comme beta-agonistes pour le traitement de maladies respiratoires
CN114763324A (zh) 一种脂质化合物及脂质体与药物组合物
EP0947507B1 (fr) Nouveaux derives de la tetrahydrobenzindolone
WO2005066140A1 (fr) Derives 3-hydroxymethyl-4-hydroxyphenyle pour le traitement de maladies des voies respiratoires
US20160304548A1 (en) Derivatives of Amphotericin B
EA013157B1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
EP1853596B1 (fr) Nouveaux betamimetiques a effet prolonge pour traiter des affections des voies respiratoires
US4876281A (en) Antifungal agents
EP2326180B1 (fr) Agents antifongiques
US6410528B1 (en) Morpholino ethers
WO1999058512A1 (fr) Ethers de morpholine
US6645960B1 (en) Antifungal sordaricin derivatives
EP0170430A1 (fr) Composés pharmaceutiques hétérocycliques, leur préparation et leur application
DE69727948T2 (de) Sordarinderivate
FI106957B (fi) Menetelmä lääkeaineina käyttökelpoisten alfa-[(2-aminoalkoksi)fenyyli]-omega-aryylialkaanien valmistamiseksi
US7199106B2 (en) Lincomycin derivatives possessing antimicrobial activity
DE102005008921A1 (de) Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
MXPA00010776A (en) Morpholino ethers
EP1228048A1 (fr) Derives carbocycliques
US20030176697A1 (en) Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents
DE69815355T2 (de) 4-cyano-4-deformylsordarinderivate

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)